ECL
55
-2
NEM
40
3
PLD
45
-5
TGT
45
-4
STZ
52
-6
RCL
83
-2
CAT
59
-2
EXC
54
3
PEP
39
-9
WHR
65
-5
ED
45
3
A
37
-2
THC
60
-5
XEL
67
2
CSCO
58
-2
VZ
44
4
TSCO
44
-4
TJX
62
-2
HSY
31
-6
JWN
48
-2
ECL
55
-2
NEM
40
3
PLD
45
-5
TGT
45
-4
STZ
52
-6
RCL
83
-2
CAT
59
-2
EXC
54
3
PEP
39
-9
WHR
65
-5
ED
45
3
A
37
-2
THC
60
-5
XEL
67
2
CSCO
58
-2
VZ
44
4
TSCO
44
-4
TJX
62
-2
HSY
31
-6
JWN
48
-2
Financhill
Back

Vanguard Intl Div Apprec ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
34

VIGI
Vanguard Intl Div Apprec ETF

Last Price:
81.38
Seasonality Move:
3.59%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
34
Vanguard Intl Div Apprec ETF (VIGI) is a Sell

Is Vanguard Intl Div Apprec ETF a Buy, Sell or Hold?

  • The current Vanguard Intl Div Apprec ETF [VIGI] share price is $81.50. The Score for VIGI is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • VIGI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VIGI Stock Price Chart

What is Vanguard Intl Div Apprec ETF's stock price today?

  • The Vanguard Intl Div Apprec ETF share price today is $81.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VIGI is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

VIGI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.01 Sell
Relative Strength Index (14 RSI): 29.17 Sell
Chaikin Money Flow: -53684 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (83.2 - 86.12) Sell
Bollinger Bands (100): (82.79 - 87.13) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

VIGI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 83.26 Sell
20-day SMA: 84.14 Sell
50-day SMA: 85.94 Sell
200-day SMA: 82.72 Sell
8-day EMA: 82.94 Sell
20-day EMA: 84.04 Sell
50-day EMA: 84.97 Sell
200-day EMA: 82.69 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Vanguard Intl Div Apprec ETF Earnings Growth & VIGI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Vanguard Intl Div Apprec ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):